BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201013
DTEND;VALUE=DATE:20201016
DTSTAMP:20260515T122955
CREATED:20200803T085442Z
LAST-MODIFIED:20200803T085442Z
UID:26601-1602547200-1602806399@www.pharmajournalist.com
SUMMARY:3rd Targeted Protein Degradation Summit
DESCRIPTION:Off the back of the newly released first-in-human data utilizing PROTACs\, it is more than ever evident that the field of targeted protein degradation is redefining the therapeutic landscape across the whole of the pharmaceutical industry. Despite the recent success\, significant challenges are continuing to hold back the progress of the discovery and development of safe and effective protein degraders. \nFor the 3rd time\, the TPD Summit is providing you with the leading platform that showcases the latest developments and advancements in the field\, bringing together the leading biopharmaceutical and academic organizations in an intimate networking environment to focus on successfully degrading intracellular & extracellular targets\, improving rational design and accelerating the translation of next generation proteasomal- & autophagy- mediated protein degraders into clinical trials. \nHere is a sneak peak of just some of our 60+ world-class speaker faculty: \n\nJay Bradner\, President\, Novartis Institutes for Biomedical Research\nCraig Crews\, John C. Malone Professor of MCDB\, Chemistry & Pharmacology\, Yale University\nAlessio Ciulli\, Professor of Chemical & Structural Biology\, University of Dundee\nMatt Disney\, Professor of Chemistry & Neuroscience\, Scripps Research\nIan Churcher\, Chief Scientific Officer\, Amphista Therapeutics\nJohn Houston\, President & Chief Executive Officer\, Arvinas\nRay Deshaies\, Senior Vice President of Global Research\, Amgen\nNello Mainolfi\, Founder\, President & Chief Executive Officer\, Kymera Therapeutics\nStewart Fisher\, Chief Scientific Officer\, C4 Therapeutics\nScott Edmondson\, Director & Head of Boston Oncology Chemistry\, AstraZeneca\nYu Shen\, Director of Cancer Biology\, AbbVie\nRichard Glynne\, Chief Scientific Officer\, Lycia Therapeutics\nIngrid Wertz\, Principal Scientist & Project Team Lead\, Genentech\n\nDon’t miss the most comprehensive\, industry-focused meeting in the field specifically dedicated to the discovery and development of targeted protein degradation strategies to advance your pipelines towards success!
URL:https://www.pharmajournalist.com/event/3rd-targeted-protein-degradation-summit/
LOCATION:Digital Event – EDT
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR